title: Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward.
abstract: BACKGROUND
  Inpatients with cutaneous adverse drug reactions (CADR) with overlapping features between maculopapular exanthema (MPE) and drug reaction with eosinophilia and systemic symptoms (DRESS) were examined.
  
  
  OBJECTIVE
  To characterize patients with exanthema and few systemic symptoms not meeting the criteria for DRESS [overlapping MPE-DRESS (MP/DR)].
  
  
  METHODS
  We undertook a comparative analysis of clinical and laboratory features of patients with MPE, MP/DR and DRESS (2008-12).
  
  
  RESULTS
  We identified 132 inpatients (85 women/47 men, mean age 64·0 ± 17·7 years) with CADR, 37 with DRESS, 28 with MPE, 34 with MP/DR and 33 with other patterns. There were no significant differences in sex, age or concomitant diseases. Allopurinol was the main cause of DRESS (40·5%) and MP/DR (29·4%); antimicrobials were the main cause in MPE (35·7%). In MP/DR the latency period (18·06 ± 13·17 days) was significantly longer than in MPE but shorter than in DRESS. Although hospitalization time was similar to DRESS (13·26 ± 7·41 days), duration of therapy and follow-up in MP/DR was shorter. Exanthema/erythroderma were frequently associated with facial oedema in MP/DR (73·5%) and DRESS (89·2%) but only in 42·0% of patients with MPE. MP/DR histopathology showed keratinocyte vacuolization and perivascular and interstitial infiltrate of lymphocytes, eosinophils and neutrophils, similar but milder than in DRESS, with less interface dermatitis, exocytosis and spongiosis. DRESS was associated with liver involvement (78·4%) and eosinophilia (78·4%), but only in 64·7% and 11·8%, respectively, of patients with MP/DR.
  
  
  CONCLUSIONS
  An overlapping pattern between MPE and DRESS was identified and characterized. There may be a continuum spectrum between MPE and DRESS.
authors.affiliation: Dermatology Department, Coimbra University Hospital Centre, Coimbra, Portugal.
authors.forename: M
authors.initials: M
authors.lastname: Pinto Gouveia
authors.affiliation: Dermatology Department, Coimbra University Hospital Centre, Coimbra, Portugal.
authors.forename: A
authors.initials: A
authors.lastname: Gameiro
authors.affiliation: Dermatology Department, Coimbra University Hospital Centre, Coimbra, Portugal.
authors.forename: I
authors.initials: I
authors.lastname: Coutinho
authors.affiliation: Dermatology Department, Coimbra University Hospital Centre, Coimbra, Portugal.
authors.forename: N
authors.initials: N
authors.lastname: Pereira
authors.affiliation: Dermatology Department, Coimbra University Hospital Centre, Coimbra, Portugal.
authors.forename: J C
authors.initials: JC
authors.lastname: Cardoso
authors.affiliation: Dermatology Department, Coimbra University Hospital Centre, Coimbra, Portugal.|Clinic of Dermatology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
authors.forename: M
authors.initials: M
authors.lastname: Gonçalo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003937:Diagnosis, Differential; D063926:Drug Hypersensitivity Syndrome / Q000175:diagnosis*; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D010267:Parapsoriasis / Q000175:diagnosis*; D012189:Retrospective Studies; D055815:Young Adult